DNASE1 and susceptibility to pneumonia measurement: For example, drug‐loaded liposome NPs (n‐DOCPs) are taken up by neutrophils and traverse the alveolar‐capillary barrier, releasing loaded dexamethasone and antibiotics through NETs in pneumonia‐affected areas to exert anti‐inflammatory effects.[63] Similarly, SA‐modified platelet membrane‐coated and deoxyribonuclease I (DNase I)‐loaded biomimetic nanozymes (D@HPB@SPM NPs) cross the blood–brain barrier via neutrophil “hitchhiking” into damaged brain parenchyma, where NETs generation releases D@HPB@SPM NPs.